A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated

NCT07526194 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3821001
DRUG: Placebo

Sponsor

Boehringer Ingelheim